КАРДИОСЕЛЕКТИВНЫЕ β-АДРЕНОБЛОКАТОРЫ ПРИ ЛЕЧЕНИИ ХСН В ПРАКТИКЕ ВРАЧА ПЕРВИЧНОГО ЗВЕНА ЗДРАВООХРАНЕНИЯ
М. Шилов, С К Дулаева · Meditsinskiy sovet = Medical Council · 2014
The article discusses the pathophysiology of CHF; it is postulated, based on the literature review, that HR is an independent risk factor for chronic heart failure. Evidence-based medicine reasonably suggests using the selective β-adrenoceptor antagonist Bisogamma (generic Bisoprolol). The authors presented own experience in treating 95 patients with CHF and, using data from dynamic observations, demonstrated the role of heart rate as an independent risk factor that determines the quality of life and prognosis, through modulation of the left ventricular diastolic function and the pumping activity of the heart.
Cited by 0 works.